Clinitech Laboratory Limited provides diagnostic and health testing and services.Business Profile The company performs over 150 tests in its centers, categorized into Biochemical Tests, Immunology Tests, Hematology Tests, Molecular Biology Tests, Serology Tests, Microbiology Tests, and Histopathology Tests.
CLINITECH LABORATORY LIMITED (CTLLAB) boosts its diagnostic capabilities with the launch of an in-house molecular department. This significant operational upgrade enables CTLLAB to perform all molecular tests internally, directly addressing patient medical needs. The move enhances the company's service offerings and operational efficiency, positioning it to improve patient care and...
Clinitech Laboratory Limited (CTLLAB) has received confirmation from its Registrar and Transfer Agent (RTA) regarding the status of its shares for the quarter ended June 30, 2025. The RTA confirmed that all company shares are held in dematerialized form. Furthermore, no requests for converting demat shares back to physical form...
Clinitech Laboratory Limited has announced a board meeting on which the Board noted the resignation of Mr. Bharat Kumar Bohra as Company Secretary & Compliance Officer and appointed Ms. Shruti Hemant Patankar to the role. The Board also approved a term loan of INR 20 lakhs from Bank of Baroda....
Clinitech Laboratory Limited has announced the resignation of Mr. Bharat Kumar Bohra from the position of Company Secretary & Compliance Officer, effective immediately. The departure is cited as being for better future prospects. This change in the company’s compliance leadership may impact corporate governance processes and shareholder communications going forward.
Clinitech Laboratory Limited has announced a statement on the utilization of funds raised through its IPO of INR 578.30 lakhs. As of the quarter ended March 31, 2025, there has been no deviation in the use of these funds, which were primarily allocated for the expansion of diagnostic centres, general...
